I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 28% ± 11% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 24% ± 7% | |
| astrocyte | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 28% ± 11% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 24% ± 7% | |
| astrocyte | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 276.87 | 1443 / 1445 | 100% | 9.20 | 183 / 183 |
| brain | 99% | 508.57 | 2625 / 2642 | 99% | 5.71 | 701 / 705 |
| skin | 100% | 437.24 | 1809 / 1809 | 99% | 6.40 | 466 / 472 |
| stomach | 99% | 219.44 | 357 / 359 | 99% | 5.29 | 282 / 286 |
| intestine | 100% | 237.00 | 966 / 966 | 98% | 3.90 | 514 / 527 |
| lung | 99% | 234.05 | 574 / 578 | 98% | 4.46 | 1129 / 1155 |
| breast | 100% | 221.63 | 457 / 459 | 97% | 3.95 | 1084 / 1118 |
| ovary | 100% | 160.21 | 180 / 180 | 96% | 4.12 | 412 / 430 |
| uterus | 100% | 250.91 | 170 / 170 | 93% | 3.49 | 427 / 459 |
| prostate | 100% | 209.81 | 244 / 245 | 93% | 2.88 | 467 / 502 |
| pancreas | 96% | 170.16 | 315 / 328 | 95% | 2.45 | 169 / 178 |
| bladder | 100% | 236.86 | 21 / 21 | 89% | 2.96 | 451 / 504 |
| thymus | 100% | 219.37 | 650 / 653 | 87% | 1.93 | 527 / 605 |
| kidney | 100% | 178.40 | 89 / 89 | 85% | 2.12 | 764 / 901 |
| adrenal gland | 100% | 298.73 | 258 / 258 | 81% | 2.43 | 186 / 230 |
| liver | 86% | 99.52 | 194 / 226 | 67% | 1.58 | 274 / 406 |
| muscle | 100% | 311.67 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 254.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.05 | 1 / 1 |
| adipose | 100% | 217.27 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 214.24 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 4.71 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 98% | 3.74 | 78 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.50 | 28 / 29 |
| peripheral blood | 95% | 289.70 | 883 / 929 | 0% | 0 | 0 / 0 |
| heart | 94% | 184.19 | 808 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
| Gene name | FBXL18 |
| Protein name | F-box and leucine rich repeat protein 18 F-box/LRR-repeat protein 18 (F-box and leucine-rich repeat protein 18) FBXL18 protein |
| Synonyms | FBL18 |
| Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. . |
| Accessions | Q96ME1 Q96D16 ENST00000382368.8 [Q96ME1-4] ENST00000415009.5 [Q96ME1-2] A0A994ENR3 ENST00000458142.1 |
